When you think of the early warning signs of diabetes, skin problems likely aren't the first thing to come to mind. But our ...

Sanofi’s potential eczema blockbuster Dupixent has got off to a strong start amid shrinking revenues in its diabetes business. Novo Nordisk posted Q3 results yesterday showing mounting sales for ...